| Metric | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $11.1B | $10.72B | Beat | +3.5% |
| Diluted EPS | $0.14 | $0.10-$0.13 | Beat | +8-40% |
| Gross Margin | 40.3% | ~39.5% | Beat | +80bps vs. est. |
| Y/Y Revenue | -12% | -15% (guided) | Beat | 3pp better |
Hill explicitly identified Q4 as "the low point" of the Win Now transformation — the moment of maximum pain from which the business inflects upward. This is a bold call for a CEO who's been in the role 8 months. If it proves correct, Q4 FY25 becomes the reference point against which every future quarter is measured favorably. If revenue declines again in Q1 FY2026, the "low point" declaration becomes a credibility-damaging broken promise.
"While our financial results are in line with our expectations, they are not where we want them to be. Moving forward, we expect our business to improve." — Elliott Hill, CEO
Assessment: The "low point" call is fundamentally a bet on the product pipeline and wholesale recovery. Hill has visibility into the Q1-Q2 FY2026 order book that investors don't — and he's choosing to declare a trough based on that private information. This is either a courageous, data-backed call or premature optimism. Q1 FY2026 (reporting September) will be the definitive test.
Hill announced the "sport offense" as the next phase after "Win Now." The framing: Win Now cleaned up the mess (inventory, DTC overexposure, cost bloat); sport offense positions Nike to grow again through athlete storytelling, performance product innovation, and sport-moment marketing. This represents the pivot from defensive restructuring to offensive brand-building — the most critical phase of any turnaround.
Assessment: The sport offense is the right framework. Nike's decline was driven by a loss of brand heat and sport credibility under prior management's DTC/lifestyle pivot. Returning to sport is returning to Nike's core. But frameworks don't produce revenue — products do. The test is whether the Hill-influenced product pipeline (starting to reach shelves in H1 FY2026) generates consumer excitement and full-price sell-through.
Nike disclosed that tariffs will cost approximately $1.5B in FY2026 and compress gross margin by ~120bps for the full year. In early FY2026 quarters, gross margin is expected to decline 400-500bps Y/Y — implying Q1-Q2 margins of 35-37%, levels not seen since pre-pandemic. Nike sources ~50% of product from Asia (China + Vietnam), and the current tariff regime creates a structural cost headwind that takes 2-3 quarters to mitigate through sourcing diversification and pricing actions.
Assessment: The tariff headwind is the single biggest risk to the turnaround timeline. Hill's "low point" declaration was about the business transformation, not tariff policy — but the market won't distinguish between sources of margin pressure if Q1 FY2026 gross margin prints 36% and revenue is still declining. The tariff overhang could delay the stock's re-rating by 2-3 quarters even if the operational turnaround proceeds as planned.
| Metric | FY2025 Actual | FY2026 Outlook | Signal |
|---|---|---|---|
| Revenue | $46.3B (-10%) | Not guided | No visibility provided |
| EPS | $2.17 (-42%) | Not guided | No visibility provided |
| Gross Margin | ~41% | -400-500bps early Qs | Tariff front-loaded |
| Tariff Cost | N/A | ~$1.5B / 120bps FY impact | New headwind |
The absence of FY2026 guidance is the most notable omission. Nike typically provides annual guidance at the Q4 report. The decision to withhold it signals genuine uncertainty about the tariff trajectory and the pace of revenue recovery. Management is essentially saying: "We know the trough is behind us, but we can't quantify the recovery because tariffs make the margin math unpredictable." This is honest but unhelpful for investors trying to value the stock.
The delayed 14% surge — modest after-hours then explosive next-day — reflects overnight institutional re-positioning. The "low point" declaration combined with the 3.5% revenue beat gave fundamental investors confidence to initiate or add positions. The magnitude of the move ($62→$72) suggests significant short covering amplified the buying — Nike was one of the most heavily shorted large-cap consumer stocks entering the print.
Bull view: Hill's "low point" call is backed by order book visibility and product pipeline data investors can't see. Revenue beat by 3.5%, and the decleration from -15% guided to -12% actual confirms deceleration of decline. The 14% surge reflects institutional conviction that the worst is over. At $72, you're buying Nike at 33x trough earnings with a CEO who knows the company better than anyone.
Bear view: Revenue is still down 12%. Gross margin is at 40.3% — COVID-era levels. Tariffs add $1.5B in costs with 400-500bps of margin pressure in early FY2026. No revenue or EPS guidance was provided because management doesn't know. At $72, the stock just repriced 14% on a narrative ("low point") that is unproven and could be undermined by a single bad Q1 print.
Our take: Both sides have merit, but the risk/reward at $72 post-surge is less attractive than it was at $62 pre-earnings. The trough thesis is credible — revenue declines are decelerating and the product pipeline should start contributing in H1 FY2026. But the tariff headwind creates 2-3 quarters of margin distortion that could obscure the underlying improvement. We'd prefer to own NKE at $62-65 with a margin of safety for tariff noise, or at $72 with clear evidence of revenue inflection in Q1 FY2026.
| Thesis Point | Status | Notes |
|---|---|---|
| Bull #1: Elliott Hill turnaround | Progressing | "Low point" declared. Revenue decline decelerating. "Sport offense" framework articulated. Two quarters of execution. |
| Bull #2: Cost discipline | Confirmed | FY25 overhead -13%. EPS beat on cost management. Restructuring largely complete. |
| Bull #3: Fortress balance sheet | Confirmed | $10.4B cash. $1.1B/Q returned to shareholders. No financial constraints. |
| Bear #1: Revenue still declining | Improving but Not Resolved | Q4 -12% (better than -15% guide). Revenue decline decelerating. But still negative. Inflection not yet achieved. |
| Bear #2: Gross margin compression | Worsening Near-Term | 40.3% (Q4 trough). Tariffs add 400-500bps headwind in early FY2026. 35-37% margins possible in Q1-Q2. |
| Bear #3: Greater China | Unresolved | Still -15% CC with no specific turnaround plan. Competitive headwinds from local brands. |
| Bear #4: Tariff risk | Confirmed — $1.5B | New headwind not in Q3 thesis. 120bps FY margin impact. Front-loaded at 400-500bps in early quarters. |
| Bear #5: No FY2026 guidance | New Concern | Withholding annual guidance = genuine uncertainty about recovery trajectory. |
Overall: Q4 delivered what the market needed: a credible "trough" narrative backed by a revenue beat. The 14% surge reflects genuine optimism about the inflection. But the tariff headwind ($1.5B, 400-500bps early quarters) and the absence of FY2026 guidance introduce new uncertainty that the stock at $72 may not adequately compensate for. The turnaround is progressing but the proof of growth is still 1-2 quarters away.
Action: Maintain Hold. The turnaround thesis strengthened with the "low point" declaration and revenue beat, but $72 post-surge is above our comfort zone given tariff uncertainty and no FY2026 guide. Upgrade triggers updated: (1) Q1 FY2026 revenue flat or positive (most important), (2) gross margin managing tariff headwind better than 400-500bps guide, (3) stock pullback to $62-65 where the margin of safety returns. Q1 FY2026 reports in September — that's the definitive test.